Skip to main content
BBWIBath & Body Works, Inc.Sell6.1·$21.64
SellModerate Confidence
Investment thesis

Bath & Body Works trades at a deeply discounted forward P/E with approximately 14% upside to the near-term price target and a roughly 2-to-1 risk/reward ratio in the buyer's favor, but a confirmed technical downtrend and a news-driven caution overlay prevent a clean entry and require the longer-term trend to repair before the valuation thesis can fully express.

Thesis pillars

  • Deep Value Favorable Risk Reward↓Deteriorating
  • Concentration Risks Amplify Downside↑Improving
  • Confirmed Downtrend Caps Technical Recovery↑Improving
  • +1 more pillar — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Mar 12, 2026

Full reasoning →

Open full analysis

Bath & Body Works, Inc. (BBWI) Stock Analysis

Recovery setup · Catalyst-Driven edge

SellValueGrowthQualityModerate Confidence

Consumer Cyclical · Specialty Retail

Sell if holding. Analyst target reached at $21.64 — A.R:R 0.0:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Sector modifier (Consumer Cyclical): -1.5.

Bath & Body Works sells personal care, home fragrance, and soap products through 1,927 company-operated North American stores and 573 international partner-operated stores as of January 31, 2026. The company had over 60,700 associates and a loyalty program with 40 million active... Read more

$21.64+0.6% A.UpsideScore 6.1/10#4 of 23 Specialty Retail
QualityF-score6 / 9FCF yield17.52%
IncomeYield3.70%(5y avg 1.99%)Payout21.05%sustainable
Stop $20.13Analyst target $21.78(−10% haircut)A.R:R 0.0:1
Analyst consensus$24.20+11.8%15 analysts
$21.78Analyst target
$21.64price
$24.20mean
$17
$54

Sell if holding. Analyst target reached at $21.64 — A.R:R 0.0:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Sector modifier (Consumer Cyclical): -1.5. Chart setup: Death cross but MACD improving, RSI 74. Score 6.1/10, moderate confidence.

Passes 5/8 gates (positive momentum, clean insider activity, earnings proximity 20d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

10-K grounded · weekly refresh

About Bath & Body Works, Inc.

About Bath & Body Works, Inc.

Bath & Body Works operated 1,927 company-operated stores in North America—60% in off-mall locations—and 573 international partner-operated stores across more than 45 countries as of January 31, 2026, with 40 million active loyalty program members. Fourth-quarter holiday selling accounted for approximately 40% of annual net sales. During 2025, the company opened 94 new North American stores, nearly all off-mall, while permanently closing 62, producing net square footage growth of 2%.

Bath & Body Works sells body care, home fragrance, soap, and sanitizer through company-operated stores, e-commerce in North America, international franchise and wholesale partners, and—beginning February 2026—on Amazon in the U.S. The company sourced merchandise from approximately 90 vendors in 2025, with the five largest supplying about 40% of merchandise purchases on a combined basis and the single largest at 12%. Production is predominantly domestic, with most third-party manufacturers and all distribution centers concentrated in central Ohio. The workforce exceeded 60,700 associates as of January 31, 2026, with 94% in stores; none are covered by a collective bargaining agreement. Store leases carry noncancelable initial terms of approximately ten years, creating fixed obligations even if a location closes before expiry. The Consumer First Formula strategic transformation, launched in the third quarter of 2025, targets attraction of younger consumers through product innovation, refreshed marketing, expanded digital access, and operational efficiency.

Show full overview

Bath & Body Works' revenue is sensitive to discretionary spending cycles: the 10-K notes that during periods when economic or market conditions are unsettled or weak, purchases have declined and the company has responded with increased promotional activity that negatively affected merchandise margin rates. The concentration of both third-party manufacturers and distribution centers in central Ohio—explicitly flagged as a risk in Item 1A—means that severe weather, a natural disaster, or a labor disruption in that region could impair supply simultaneously. The Consumer First Formula requires significant near-term investment that the company acknowledges may be dilutive to earnings in the short term.

See also: Consumer Cyclical · Specialty Retail

From Bath & Body Works, Inc.'s most recent 10-K filing, extracted June 9, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-10-29
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Nov 19, 202620d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
Attractive valuation
Margin of safety: 68%
Risks
Analyst target reached - limited upside remaining
Sector modifier (Consumer Cyclical): -1.5

Key Metrics

P/E (TTM)5.7
P/E (Fwd)7.8
Mkt Cap$4.4B
EV/EBITDA6.3
Profit Mgn10.8%
ROE—
Rev Growth-2.3%
Beta1.40
Dividend3.70%
Rating analysts25

Quality Signals

Piotroski F6/9

Options Flow

P/C0.08bullish
IV70%elevated
Max Pain$16-28.4% vs spot

Concentration Risks(10-K Item 1A)

  • LOWSupplierlargest vendor
    10-K Item 1: 'Our largest vendor supplied approximately 12% of our total merchandise purchases (on a dollar basis) during 2025'
  • MEDIUMSupplierfive largest vendors
    10-K Item 1: 'Our five largest vendors supplied approximately 40% of our total merchandise purchases (on a dollar basis) on a combined basis during 2025'
  • MEDIUMSupplierlimited number of suppliers
    10-K Item 1A: 'our reliance on a limited number of suppliers to support a substantial portion of our inventory purchasing needs'
  • MEDIUMGeographiccentral Ohio manufacturing and distribution
    10-K Item 1A: 'the geographic concentration of third-party manufacturing facilities and our distribution facilities in central Ohio'

Material Events(8-K, last 90d)

  • 2026-05-27Item 5.02MEDIUM
    CFO Eva C. Boratto resigned effective June 12, 2026 to pursue another professional opportunity. Tom Javitch appointed Interim CFO and D. Andrew Meeting appointed SVP Controller and Principal Accounting Officer, both effective June 12, 2026.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Support Resistance
0.6
Bollinger
1.8
Gap
6.0
52w Position
6.5
GatesA.R:R 0.0 < 1.5@spotDeath cross (50MA < 200MA)Executive change: officer departure/appointmentMomentum 6.7>=5.5Insider activity: OKEARNINGS PROXIMITY 20d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Aggressive
RSI
74 · Overbought
↑ 20D MA↑ 50D MA↑ 200D MADEATH CROSSSupport $16.05Resistance $22.02

Price Targets

$20
$22
A.Upside+0.6%
A.R:R0.0:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! Target reached (0.6% upside)
! asymmetry at 0.0 (below the engine's 1.5 threshold)@spot

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-11-19 (20d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is BBWI stock a buy right now?

Sell if holding. Analyst target reached at $21.64 — A.R:R 0.0:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Sector modifier (Consumer Cyclical): -1.5. Chart setup: Death cross but MACD improving, RSI 74. Prior stop was $20.13. Score 6.1/10, moderate confidence.

What is the BBWI stock price target?

Analyst target: $21.78 (+0.6% upside). Prior stop was $20.13. Stop-loss: $20.13.

What are the risks of investing in BBWI?

Analyst target reached - limited upside remaining; Sector modifier (Consumer Cyclical): -1.5.

Is BBWI overvalued or undervalued?

Bath & Body Works, Inc. trades at a P/E of 5.7 (forward 7.8). TrendMatrix value score: 8.3/10. Verdict: Sell.

What do analysts say about BBWI?

25 analysts cover BBWI with a consensus score of 3.6/5. Average price target: $24.

What does Bath & Body Works, Inc. do?Bath & Body Works sells personal care, home fragrance, and soap products through 1,927 company-operated North American...

Bath & Body Works sells personal care, home fragrance, and soap products through 1,927 company-operated North American stores and 573 international partner-operated stores as of January 31, 2026. The company had over 60,700 associates and a loyalty program with 40 million active members; fourth-quarter sales account for approximately 40% of annual net sales. A multi-year Consumer First Formula transformation launched in the third quarter of 2025.

Related stocks: BWMX (Betterware de Mexico, S.A.P.I. ) · MUSA (Murphy USA Inc.) · FIVE (Five Below, Inc.) · CASY (Caseys General Stores, Inc.) · EYE (National Vision Holdings, Inc.)
Home › Stocks › BBWI

Latest news

Latest News

The Motley Fool155d ago
Benzinga155d ago
StocksToTrade155d ago
GuruFocus155d ago
MarketBeat155d ago
Seeking Alpha155d agoEarnings
MarketBeat155d agoEarnings
Qz.com155d ago
Seeking Alpha155d ago
CNBC155d ago
KING5.com155d agoEarnings
KVUE155d agoEarnings
Investing.com Nigeria64d ago
StocksToTrade64d agoAnalyst
GuruFocus64d ago
Finance.yahoo.com64d ago
Yahoo Finance64d ago
Seeking Alpha64d ago
Yahoo Finance64d ago
Morningstar64d ago
Loading more...